Jakub Hlavka : Citation Profile

University of Southern California (1% share)
Masarykova Univerzita (99% share)

1

H index

0

i10 index

4

Citations

RESEARCH PRODUCTION:

4

Articles

1

Papers

RESEARCH ACTIVITY:

   6 years (2016 - 2022). See details.
   Cites by year: 0
   Journals where Jakub Hlavka has often published
   Relations with other researchers
   Recent citing documents: 3.    Total self citations: 0 (0 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/phl25
   Updated: 2025-03-08    RAS profile: 2024-01-11    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Jakub Hlavka.

Is cited by:

Magnac, Thierry (1)

LEVAGGI, ROSELLA (1)

Dubois, Pierre (1)

Boes, Stefan (1)

Cites to:

Lakdawalla, Darius (7)

Goldman, Dana (3)

Romer, Paul (2)

Sood, Neeraj (2)

Jones, Charles (2)

Philipson, Tomas (2)

Chen, Alice (1)

Etro, Federico (1)

Towse, Adrian (1)

Main data

Production by document typearticlepaper201620172018201920202021202200.511.5Documents Highcharts.comExport to raster or vector imagePrint the chart
Cumulative documents published20162017201820192020202120220246Documents Highcharts.comExport to raster or vector imagePrint the chart

Citations received20222023202420250123Citations Highcharts.comExport to raster or vector imagePrint the chart
Citations by production year20202021202201234Citations Highcharts.comExport to raster or vector imagePrint the chart

H-Index: 1Most cited documents123024Number of citations Highcharts.comExport to raster or vector imagePrint the chart
H-Index evolution20240420240520240620240720240820240920241020241120241220250120250220250300.511.5h-index Highcharts.comExport to raster or vector imagePrint the chart

Where Jakub Hlavka has published?

Recent works citing Jakub Hlavka (2025 and 2024)

Year  ↓Title of citing document  ↓
2024Optimal intertemporal curative drug expenses: The case of hepatitis C in France. (2024). Magnac, Thierry ; Dubois, Pierre. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s0167629624000067.

Full description at Econpapers || Download paper

2024Competition, value-based prices and incentives to research personalised drugs. (2024). Levaggi, Rosella. In: Socio-Economic Planning Sciences. RePEc:eee:soceps:v:93:y:2024:i:c:s0038012124000697.

Full description at Econpapers || Download paper

2025Competition matters: uniform vs. indication-based pricing of pharmaceuticals. (2025). Dalen, Dag Morten ; Brekke, Kurt R ; Straume, Odd Rune. In: Discussion Paper Series in Economics. RePEc:hhs:nhheco:2025_001.

Full description at Econpapers || Download paper

Works by Jakub Hlavka:

Year  ↓Title  ↓Type  ↓Cited  ↓
2017Portfolio Society: On the Capitalist Mode of Prediction In: Science and Public Policy.
[Full Text][Citation analysis]		article0
2016A Change is in the Air Emerging Challenges for the Cloud Computing Industry In: Working Papers.
[Full Text][Citation analysis]		paper0
2020The Potential Benefits of Deferred Payment for a Hypothetical Gene Therapy for Congestive Heart Failure: A Cost-Consequence Analysis In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article1
2021The economics of alternative payment models for pharmaceuticals In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article3
2022Addressing Challenges to Alternative Payment Models for New Alzheimer’s Disease Therapies for US Commercial Payers In: PharmacoEconomics.
[Full Text][Citation analysis]		article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated February, 4 2025. Contact: CitEc Team